Vaccine

The products, which are widely available in the US and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions

Country now depends on foreign companies and Serum's product is likely to bring down prices.

Smallpox vaccines are around 85 per cent effective in preventing monkeypox infection, and several countries have said they have begun stockpiling them

Domestically produced variant-proof jabs are part of a global project to develop vaccines for future epidemics

The privately held company has a turnover of about Rs 1,000 crore, of which close to 70-80 per cent come from the vaccines business now

The Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) recently announced the development of the country's first potential mRNA vaccine candidate to fight against SARS-CoV-2

Serum Institute of India is the world's largest company in terms of Covid-19 vaccine production having manufactured over 500 million doses

On May 4, Biological E submitted an application seeking emergency use authorisation for its Covid vaccine Corbevax as a booster dose in adults fully vaccinated with Covishield or Covaxin

What is Corbevax, the Covid-vaccine for your 5-year-old?

The DCGI has recently approved the emergency use of Covid-19 vaccine Corbevax for children aged five to 12. Find out more about the new vaccine and how it can boost the immune response

A senior government official had told Business Standard last week that so far there was no scientific evidence to expand the vaccination programme to young children

A dose of Covovax will cost Rs 900 plus GST, in addition to hospital service charge of Rs 150, official sources told PTI

Covid booster shots won't be mandatory for all, says K Srinath Reddy

As cases of Covid-19 are rising in India, Business Standard's Bhaswar Kumar spoke to K Srinath Reddy, president of Public Health Foundation of India, about how the fourth wave is likely to play out

The article on 'State of the Economy', published in the April 2022 RBI Bulletin, said India enters Samvat 2079 having crested the third wave of the pandemic

He said that the lockdown and closure of schools will not be the solution to deal with the pandemic

The move comes as the national capital witnesses an uptick in coronavirus cases and a rise in positivity rate

SII and Bharat Biotech have been major suppliers of Covid-19 vaccines to the government so far

The three-dose vaccine, named as 'ThRabis', is a recombinant nano-particle based G protein vaccine which is prepared using Virus-like Particle technology

Around 22.8 mn precaution or booster dose have been administered to healthcare and frontline workers along with senior citizens after the population segments opened up in the first week of January.

The portal already has a feature that allows one to rectify inadvertent errors in name, year of birth and gender on vaccination certificates

Vaccination programme cannot lose govt attention